Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Financing of medical products in South Africa

Thesis (MMed)--Stellenbosch University, 2019.

Saved in:
Bibliographic Details
Main Author: Mamdoo, Punithasvaree
Other Authors: Begg, Kerrin
Format: Thesis
Language:en_ZA
Published: Stellenbosch : Stellenbosch University 2019
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613739766775808
access_status_str Open Access
author Mamdoo, Punithasvaree
author2 Begg, Kerrin
author_browse Begg, Kerrin
Mamdoo, Punithasvaree
author_facet Begg, Kerrin
Mamdoo, Punithasvaree
author_sort Mamdoo, Punithasvaree
collection Thesis
dc_rights_str_mv Stellenbosch University
description Thesis (MMed)--Stellenbosch University, 2019.
format Thesis
id oai:scholar.sun.ac.za:10019.1/107030
institution Stellenbosch University (South Africa)
language en_ZA
last_indexed 2026-06-10T12:40:56.191Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from SUNScholar — Stellenbosch University Repository
publishDate 2019
publishDateRange 2019
publishDateSort 2019
publisher Stellenbosch : Stellenbosch University
publisherStr Stellenbosch : Stellenbosch University
record_format dspace
source_str SUNScholar — Stellenbosch University Repository
spelling oai:scholar.sun.ac.za:10019.1/107030 Financing of medical products in South Africa Mamdoo, Punithasvaree Begg, Kerrin Stellenbosch University. Faculty of Medicine and Health Sciences. Dept. of Global Health. Health Systems & Public Health. Health products -- South Africa Health services accessibility -- South Africa Medical care -- Finance -- South Africa Medical care, Cost of -- South Africa Medical policy -- South Africa UCTD Thesis (MMed)--Stellenbosch University, 2019. ENGLISH SUMMARY : Background: Medical products (encompassing medicines and medical devices) are critical health system building blocks; access to medical products (ATM) impact clinical outcomes. However, cost and operational inefficiencies in the health system limits ATM. Funding strategies and policy reforms are key instruments in managing the supply and demand side determinants of ATM. Objectives: This study aimed to 1) analyse the South African(SA) regulatory framework for medical products; 2) review expenditure on medical products at Private, Public and Household levels; and 3) describe ATM using the WHO Building Blocks framework and 4) gauge the status of supply and demand side determinants of ATM. Methodology: A mixed methods study design was used to represent ATM complexity in the health system. USAID’s Health System Assessment Approach was used to analyse the enabling legislative and regulatory landscape for ATM in SA. Unpublished National Treasury, provincial Departments of Health and Council for Medical Schemes Annual Reports were sources for the descriptive trend analysis of public and private sector medical products expenditure. Household out-of-pocket expenditure was analysed from Statistics SA national household survey data. With data from key informant interviews, a systems diagram was constructed. District Health information system and national survey data was used to present current system performance using supply and demand side indictors of ATM. Results: Medical products expenditure is a major cost driver in the private sector. Households with medical aid, spent more OOP on medical products than the uninsured; province, household size and income sources were not significant factors in estimating medical products expenditure. In the public sector, trends demonstrate increasing investment in medical products, however indicators of supply side ATM determinants show poor performance. In 2014, health contributed 0.9 %( R935) of total household expenditure; which does not constitute catastrophic expenditure levels. A larger proportion of total health spending is on medical products (0.7%) than outpatient medical services (0.6%) in average SA households; pharmaceutical expenditure dominates (90%) compared to therapeutic appliances and other medical products combined (10%). In uninsured households NC and LP provinces and Indian and White population groups were the only statistically significant variables in estimating expenditure. Male headed households spend more actual Rands on medical products than female headed households. A R31.00 decrease in expenditure for rural insured households was calculated for each increase in expenditure by urban insured households. Households in FS, NW, EC and NC had the highest OOP expenditures on medical products. Households in LP had the lowest OOP expenditure on medical products in the survey period. Conclusions and Recommendations: There are opportunities in the scale up to UHC to implement policy options to increase ATM. Capacity building is needed to ensure equitable fiscal allocations, ability to absorb resources and optimise service delivery within government. Need for improved monitoring and data analytics of cost, access and utilisation of medical products at public health facilities; OOP spending on medical products in private sector in terms of outpatient and hospitalisation and survey data at household level spending. Managed care Organisations can contribute to ATM through quality and clinical governance in the private sector. AFRIKAANSE OPSOMMING : Geen opsomming beskikbaar. Masters 2019-09-02T21:04:44Z 2019-12-11T06:44:10Z 2019-09-02T21:04:44Z 2019-12-11T06:44:10Z 2019-12 Thesis http://hdl.handle.net/10019.1/107030 en_ZA Stellenbosch University 103 pages ; illustrations, includes annexures application/pdf Stellenbosch : Stellenbosch University
spellingShingle Health products -- South Africa
Health services accessibility -- South Africa
Medical care -- Finance -- South Africa
Medical care, Cost of -- South Africa
Medical policy -- South Africa
UCTD
Mamdoo, Punithasvaree
Financing of medical products in South Africa
title Financing of medical products in South Africa
title_full Financing of medical products in South Africa
title_fullStr Financing of medical products in South Africa
title_full_unstemmed Financing of medical products in South Africa
title_short Financing of medical products in South Africa
title_sort financing of medical products in south africa
topic Health products -- South Africa
Health services accessibility -- South Africa
Medical care -- Finance -- South Africa
Medical care, Cost of -- South Africa
Medical policy -- South Africa
UCTD
url http://hdl.handle.net/10019.1/107030
work_keys_str_mv AT mamdoopunithasvaree financingofmedicalproductsinsouthafrica